APA (7th ed.) Citation

Jadersten, M., Pellagatti, A., Forsblom, A., Emanuelsson, E., Merup, M., Samuelsson, J., . . . Hellstorm-Lindberg, E. (2005). Lenalidomide selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5q deletion.

Chicago Style (17th ed.) Citation

Jadersten, M., A. Pellagatti, A. Forsblom, E. Emanuelsson, M. Merup, J. Samuelsson, J. Wainscoat, J. Boultwood, and E. Hellstorm-Lindberg. Lenalidomide Selectively Inhibits in Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion. 2005.

MLA (9th ed.) Citation

Jadersten, M., et al. Lenalidomide Selectively Inhibits in Vitro Growth of the Malignant Clone in Myelodysplastic Syndrome (MDS) Patients with 5q Deletion. 2005.